DXCM Financial Facts

Product revenue: 104.2M
Development and other cost of sales: 0
See Full Income Statement

Restricted cash: 0
Accounts receivable, net: 55.8M
See Full Balance Sheet

DexCom, Inc. (DXCM) Earnings

  |   Expand Research on DXCM
Next EPS Date 2/23/16 EPS Growth Rate -100.0%
Average EPS % Beat Rate -138.6% Revenue Growth Rate +45.8%
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/23/16 Q415 N/A$0.00 N/A N/A$122.93M N/A N/A N/A
11/4/15 Q315 -$0.07-$0.01 -$0.06$105.2M$99.88M N/A Details
8/5/15 Q215 -$0.05-$0.03 -$0.02$93.2M$84.81M N/A Details
4/29/15 Q115 -$0.17-$0.11 -$0.06$72.8M$71.32M N/A Details
2/25/15 Q414 $0.02-$0.03 +$0.05$84.3M$79.65M N/A Details
11/6/14 Q314 -$0.07-$0.06 -$0.01$69M$60.2M N/A Details
8/6/14 Q214 -$0.08-$0.10 +$0.02$58.8M$52.45M N/A Details
5/1/14 Q114 -$0.17-$0.08 -$0.09$46.7M$44.15M N/A Details